Patent classifications
A23K20/116
EDIBLE PET CHEW TOY AND METHOD AND SYSTEM FOR USE
An edible dog chew toy includes: (i) a tough chewable material (e.g., a natural rawhide or a synthetic “rawhide-type” material); and (ii) one or more active ingredients that are useful for promoting a calming effect on a dog. The toy is extremely appetizing for dogs, and the smell and taste of the toy (or a treat member provided therein) constantly entices the dog to chew the toy over a substantial portion of the life of the toy.
Complex Containing Betaine, Transition Metal and Sulfate
Complex containing betaine, transition metal and sulfate in a ratio of 1:1:1, the transition metal being coordinated with two oxygen atoms from the betaine.
Compounds and methods for treating nematode infections
The present application relates to the treatment of nematode infections. For example, the application relates to the use of compounds of Formula (I) and/or (II) as defined herein for treatment of a nematode infection or a disease, disorder or condition arising from a nematode infection: ##STR00001##
Compounds and methods for treating nematode infections
The present application relates to the treatment of nematode infections. For example, the application relates to the use of compounds of Formula (I) and/or (II) as defined herein for treatment of a nematode infection or a disease, disorder or condition arising from a nematode infection: ##STR00001##
CONTROLLED RELEASE OF CAFFEINE
The present invention relates to an edible composition having a lipid continuous phase and self-assembled structures, the composition comprising oil, phospholipids, caffeine and water. Further aspects of the invention are the use of a composition to provide controlled release of caffeine, a composition for use in the treatment or prevention of drowsiness, the non-therapeutic use of a composition to increase mental alertness, and an edible capsule.
CONTROLLED RELEASE OF CAFFEINE
The present invention relates to an edible composition having a lipid continuous phase and self-assembled structures, the composition comprising oil, phospholipids, caffeine and water. Further aspects of the invention are the use of a composition to provide controlled release of caffeine, a composition for use in the treatment or prevention of drowsiness, the non-therapeutic use of a composition to increase mental alertness, and an edible capsule.
SRC INHIBITOR COMPOUNDS FOR SKELETAL MUSCLE MODULATION, METHODS AND USES THEREOF
The present invention relates to novel SRC inhibitor compounds for improving skeletal muscle regeneration to maintain or increase muscle function and/or muscle mass by modulating muscle stem cells. For example, the present invention is useful for subjects to promote muscle repair and/or subjects suffering from precachexia, cachexia, sarcopenia, myopathy, dystrophy and/or recovery after muscle injury or surgery.
Controlled release of caffeine
The present invention relates to an edible composition having a lipid continuous phase and self-assembled structures, the composition comprising oil, phospholipids, caffeine and water. Further aspects of the invention are the use of a composition to provide controlled release of caffeine, a composition for use in the treatment or prevention of drowsiness, the non-therapeutic use of a composition to increase mental alertness, and an edible capsule.
Controlled release of caffeine
The present invention relates to an edible composition having a lipid continuous phase and self-assembled structures, the composition comprising oil, phospholipids, caffeine and water. Further aspects of the invention are the use of a composition to provide controlled release of caffeine, a composition for use in the treatment or prevention of drowsiness, the non-therapeutic use of a composition to increase mental alertness, and an edible capsule.
FEED ADDITIVE FOR FARMED ANIMALS
A use of pyrroloquinoline quinone (PQQ) for at least one of preserving the quality of meat obtained from farmed animals, relates to preventing the apparition of the defaults in meat, limiting, stopping the development of defaults in meat. The defaults are linked to myopathy, with farmed animals, and preparing a feed additive or a premix in order to preserve the quality of meat obtained from farmed animals and/or in order to at least one of preventing the apparition of the defaults in meat, limiting and stopping the development of defaults in meat. The defaults are linked to myopathy, with farmed animals. The use also relates to feed additive, a feed and a premix having PQQ.